CoChat

Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public

Etter, J · 2001 · Clinical Pharmacology & Therapeutics
Cited by 148

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Nicotine replacement therapy (NRT) doubles the chances that a smoker will quit smoking, but most smokers who attempt to quit do not use it at all or only use it inconsistently. We aimed to identify attitudes of smokers and ex-smokers toward NRT and to develop and assess the validity of a brief scale used to measure these attitudes. METHODS: We conducted a first mail survey of 256 smokers and ex-smokers to collect qualitative data and to develop survey items and a second mail survey of 494 smokers and ex-smokers to finalize the scale and assess its validity. The study was conducted in Geneva, Switzerland, in 1998 to 1999. RESULTS: The study resulted in a 2-dimensional, 12-item scale: the Attitudes Toward Nicotine Replacement Therapy scale (ANRT-12). The 2 subscales measure perception of the advantages of NRT (8 items) and the drawbacks of NRT (4 items). Internal consistency coefficients (alpha = 0.84 and 0.75, respectively) and test-retest correlations (0.79 for both scales) were high. The scales respected criteria of content and construct validity. Scores were associated with intention to use NRT, and among those who had ever used NRT, with the number of days of use. A disturbing result was that only 1 (16%) of 6 participants agreed that "NRT helps people quit smoking," and only 1 (24%) of 4 ex-smokers had ever used NRT. CONCLUSIONS: Many smokers and ex-smokers have inadequate knowledge of and negative attitudes toward NRT. ANRT-12 is a valid and reliable measure of these attitudes; it can be used by clinicians, researchers, and educators to improve use of and compliance with NRT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1067/mcp.2001.113722

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 148

Metadata

Authors
Etter, J.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2001-03
Volume
69
Issue
3
Pages
175-183
ISSN
0009-9236 (ISSN-L)
OpenAlex
W2169474816
Cited by
148
References
5
FWCI
2.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.